by Walter Gunzburg | Aug 13, 2026 | Press Release
This press release can be viewed online at: https://www.globenewswire.com/news-release/2026/08/12/3343647https://www.einpresswire.com/article/634030792/ Agreement combines Austrianova’s Cell-in-a-Box® technology with San Raffaele Hospital’s stem cell-derived beta cell...
by Walter Gunzburg | May 21, 2026 | News
LAS VEGAS, May 20, 2026 /PRNewswire/ — Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today...
by Walter Gunzburg | Apr 23, 2026 | News
“SG Austria/Austrianova appoints biotech investor C. Thomas Paschall to its Board following a successful 2025 funding round, strengthening global growth, partnerships, and strategic expansion initiatives.” SINGAPORE – April 21, 2026 – SG...
by Walter Gunzburg | Nov 19, 2025 | News, Press Release
LAS VEGAS, NEVADA, November 18, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders, today announced that its 50/50 joint venture...
by Walter Gunzburg | Sep 19, 2025 | News, Press Release
LAS VEGAS, Sept. 18, 2025 /PRNewswire/ — Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and Austrianova (SGAustria Pte. Ltd.), a Singapore-based biotechnology leader, today announced the...